Clinical Trial Update: Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

This document announces the termination of a Phase 1 dose-escalation study of CHR-5154 in healthy male volunteers, assessing safety, tolerability, food effect a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CHR-5154

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: TERMINATED